TNF Pharmaceuticals, Inc. (TNFA) — Capital Reinvestment Ratio
TNF Pharmaceuticals, Inc. (TNFA) has a Capital Reinvestment Ratio of 0.44x as of December 2008, meaning it reinvests 0% of its operating cash flow ($469.37K) in capital expenditures ($208.51K). Check TNF Pharmaceuticals, Inc. tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
TNF Pharmaceuticals, Inc. Capital Reinvestment Ratio (2007–2008)
This chart tracks TNF Pharmaceuticals, Inc.'s Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see TNF Pharmaceuticals, Inc. cash conversion from operations.
Annual Capital Reinvestment Ratio for TNF Pharmaceuticals, Inc. (2007–2008)
Year-by-year Capital Reinvestment Ratio for TNF Pharmaceuticals, Inc. from 2007 to 2008. See TNF Pharmaceuticals, Inc. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2008 | 0.44x | $469.37K | $208.51K | ▲ +285.6% |
| 2007 | 0.12x | $182.19K | $20.99K | — |